Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1986 5
1987 4
1988 2
1989 10
1990 6
1991 3
1992 3
1993 1
1994 4
1995 1
1996 1
1997 2
2000 3
2001 1
2002 5
2003 3
2004 2
2005 5
2006 2
2007 2
2008 7
2009 6
2010 2
2011 6
2012 10
2013 1
2014 3
2015 7
2016 10
2017 7
2018 5
2019 3
2020 7
2021 4
2022 3
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
NNRTIs: pharmacological data.
Dellamonica P, Di Perri G, Garraffo R. Dellamonica P, et al. Among authors: garraffo r. Med Mal Infect. 2012 Jul;42(7):287-95. doi: 10.1016/j.medmal.2012.05.004. Epub 2012 Jun 22. Med Mal Infect. 2012. PMID: 22727649 Review.
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G. Benaboud S, et al. Among authors: garraffo r. J Antimicrob Chemother. 2023 Mar 2;78(3):853-854. doi: 10.1093/jac/dkad009. J Antimicrob Chemother. 2023. PMID: 36683308 No abstract available.
NNRTIs: future prospects.
Dellamonica P, Di Perri G, Garraffo R. Dellamonica P, et al. Among authors: garraffo r. Med Mal Infect. 2012 Jul;42(7):296-300. doi: 10.1016/j.medmal.2012.05.005. Epub 2012 Jun 23. Med Mal Infect. 2012. PMID: 22727648 Review.
Fetoplacental passage of zidovudine.
Gillet JY, Garraffo R, Abrar D, Bongain A, Lapalus P, Dellamonica P. Gillet JY, et al. Among authors: garraffo r. Lancet. 1989 Jul 29;2(8657):269-70. doi: 10.1016/s0140-6736(89)90449-2. Lancet. 1989. PMID: 2569069 No abstract available.
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C; ANRS-AC43 Clinical Pharmacology Committee, SFPT Therapeutic Drug Monitoring and Treatment Personalization group. Venisse N, et al. Among authors: garraffo r. Antiviral Res. 2020 Sep;181:104866. doi: 10.1016/j.antiviral.2020.104866. Epub 2020 Jul 10. Antiviral Res. 2020. PMID: 32659293 Free PMC article. Review.
146 results